Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at B. Riley from $33.00 to $42.00. They now have a "buy" rating on the stock.
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Guggenheim from $28.00 to $43.00. They now have a "buy" rating on the stock.
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program [Yahoo! Finance]
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Wells Fargo & Company from $30.00 to $35.00. They now have an "overweight" rating on the stock.